Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Assembly Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 45 | 24 | −21 |
| SharesConverted for a 1-for-12 split | 720.7K | 647.3K | −73.4K (−10.2%) |
| Value | $7.09M | $8.61M | +$1.52M (+21.4%) |
New holders (0)
Institutions that held Assembly Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (21)
Institutions that held Assembly Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Anson Funds Management LP | 719,470 | $590.0K |
| Two Sigma Investments, LP | 135,048 | $110.8K |
| Citadel Advisors LLC | 124,914 | $102.4K |
| Susquehanna International Group, LLP | 71,770 | $58.9K |
| Franklin Resources Inc | 65,392 | $53.6K |
| Jane Street Group, LLC | 44,898 | $36.8K |
| XTX Topco Ltd | 41,453 | $34.0K |
| Two Sigma Advisers, LP | 33,200 | $27.2K |
| Charles Schwab Investment Management Inc | 32,452 | $26.6K |
| HRT Financial LP | 30,518 | $25.0K |
| Commonwealth Equity Services, LLC | 16,621 | $14.0K |
| Bank of New York Mellon Corp | 15,866 | $13.0K |
| RBF Capital, LLC | 14,741 | $12.1K |
| HSBC Holdings PLC | 11,413 | $9.42K |
| Palumbo Wealth Management LLC | 10,075 | $8.26K |
| Engineers Gate Manager LP | 10,071 | $8.26K |
| Clear Street Markets LLC | 5,000 | $4.00K |
| BNP Paribas Arbitrage, SA | 32 | $26 |
| Bank of America Corp | 29 | $24 |
| Advisory Services Network, LLC | 1 | $1 |
| Simplex Trading, LLC | 73 | $0 |